Ascendis Pharma A (ASND) Notes Payables (2021 - 2025)
Historic Notes Payables for Ascendis Pharma A (ASND) over the last 5 years, with Q4 2025 value amounting to $499.9 million.
- Ascendis Pharma A's Notes Payables rose 209.08% to $499.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $499.9 million, marking a year-over-year increase of 209.08%. This contributed to the annual value of $485.3 million for FY2025, which is 89.5% down from last year.
- Ascendis Pharma A's Notes Payables amounted to $499.9 million in Q4 2025, which was up 209.08% from $771.6 million recorded in Q3 2025.
- Ascendis Pharma A's Notes Payables' 5-year high stood at $771.6 million during Q3 2025, with a 5-year trough of $8.0 million in Q4 2021.
- In the last 5 years, Ascendis Pharma A's Notes Payables had a median value of $636.7 million in 2024 and averaged $501.9 million.
- Per our database at Business Quant, Ascendis Pharma A's Notes Payables soared by 359146.39% in 2023 and then tumbled by 288.3% in 2025.
- Ascendis Pharma A's Notes Payables (Quarter) stood at $8.0 million in 2021, then surged by 48.28% to $11.9 million in 2022, then surged by 3591.46% to $438.0 million in 2023, then increased by 11.79% to $489.6 million in 2024, then grew by 2.09% to $499.9 million in 2025.
- Its Notes Payables was $499.9 million in Q4 2025, compared to $771.6 million in Q3 2025 and $684.4 million in Q2 2025.